Table 3.
Clinical trials of dendritic cell (DC) vaccine in ovarian cancer registered on ClinicalTrials.gov.
| Status (up to 2020.2) | NCT number | Treatment | Number enrolled |
|---|---|---|---|
| Not yet recruiting | NCT03735589 | DCV, autologous NK cell-like CTLs | 18 |
| NCT03905902 | DCV | 678 | |
| Active/Recruiting | NCT00799110 | DCV+GM-CSF, DCV+ GM-CSF+ Imiquimod | 23 |
| NCT02033616 | DCV+GM-CSF, autologous monocytes+GM-CSF | 99 | |
| NCT02111941 | DCV | 19 | |
| NCT00703105 | DCV | 36 | |
| Completed | NCT01617629 | DCV | 9 |
| NCT01068509 | DCV | 63 | |
| NCT00478452 | DCV, DCV+ Cyclophosphamide | 14 | |
| NCT00683241 | DCV | 36 | |
| NCT01132014 | DCV | 67 | |
| NCT01522820 | DCV+ Sirolimus | 18 | |
| NCT00844506 | DCV+ Cyclophosphamide | 19 | |
| NCT00648102 | DCV | 36 | |
| NCT00019084 | DCV, DCV+ autologous lymphocytes | 70 | |
| NCT00004604 | DCV | 24 | |
| NCT00027534 | DCV | 14 |
DCV, dendritic cell vaccine; GM-CSF, granulocyte-macrophage colony stimulating factor; NK cell, natural killer cell.